Annual EBITDA
-$67.45 M
-$281.61 M-131.49%
31 December 2023
Summary:
Fulgent Genetics annual earnings before interest, taxes, depreciation & amortization is currently -$67.45 million, with the most recent change of -$281.61 million (-131.49%) on 31 December 2023. During the last 3 years, it has fallen by -$360.57 million (-123.01%). FLGT annual EBITDA is now -109.82% below its all-time high of $686.96 million, reached on 31 December 2021.FLGT EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$12.60 M
+$155.00 K+1.22%
30 September 2024
Summary:
Fulgent Genetics quarterly earnings before interest, taxes, depreciation & amortization is currently -$12.60 million, with the most recent change of +$155.00 thousand (+1.22%) on 30 September 2024. Over the past year, it has dropped by -$25.95 million (-194.37%). FLGT quarterly EBITDA is now -104.69% below its all-time high of $268.84 million, reached on 31 March 2021.FLGT Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$80.98 M
-$25.95 M-47.14%
30 September 2024
Summary:
Fulgent Genetics TTM earnings before interest, taxes, depreciation & amortization is currently -$80.98 million, with the most recent change of -$25.95 million (-47.14%) on 30 September 2024. Over the past year, it has dropped by -$36.13 million (-80.53%). FLGT TTM EBITDA is now -110.66% below its all-time high of $759.64 million, reached on 30 September 2021.FLGT TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FLGT EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -131.5% | -194.4% | -80.5% |
| 3 y3 years | -123.0% | -107.8% | -110.7% |
| 5 y5 years | -2220.3% | -726.1% | -7894.4% |
FLGT EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -109.8% | at low | -106.1% | +68.9% | -110.7% | at low |
| 5 y | 5 years | -109.8% | at low | -104.7% | +68.9% | -110.7% | at low |
| alltime | all time | -109.8% | at low | -104.7% | +68.9% | -110.7% | at low |
Fulgent Genetics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$12.60 M(-1.2%) | -$80.98 M(+47.1%) |
| June 2024 | - | -$12.75 M(-15.7%) | -$55.04 M(-1.3%) |
| Mar 2024 | - | -$15.13 M(-62.6%) | -$55.77 M(-4.8%) |
| Dec 2023 | -$67.45 M(-131.5%) | -$40.50 M(-403.4%) | -$58.58 M(+30.6%) |
| Sept 2023 | - | $13.35 M(-199.0%) | -$44.86 M(-6.4%) |
| June 2023 | - | -$13.49 M(-24.8%) | -$47.93 M(+360.5%) |
| Mar 2023 | - | -$17.95 M(-33.0%) | -$10.41 M(-104.9%) |
| Dec 2022 | $214.16 M(-68.8%) | -$26.78 M(-360.5%) | $214.16 M(-45.8%) |
| Sept 2022 | - | $10.28 M(-57.2%) | $395.29 M(-27.8%) |
| June 2022 | - | $24.04 M(-88.4%) | $547.46 M(-12.4%) |
| Mar 2022 | - | $206.63 M(+33.9%) | $624.74 M(-9.1%) |
| Dec 2021 | $686.96 M(+134.4%) | $154.35 M(-5.0%) | $686.96 M(-9.6%) |
| Sept 2021 | - | $162.45 M(+60.3%) | $759.64 M(+14.8%) |
| June 2021 | - | $101.32 M(-62.3%) | $661.44 M(+17.4%) |
| Mar 2021 | - | $268.84 M(+18.4%) | $563.31 M(+92.2%) |
| Dec 2020 | $293.12 M(>+9900.0%) | $227.03 M(+253.4%) | $293.12 M(+342.5%) |
| Sept 2020 | - | $64.25 M(+1914.6%) | $66.24 M(+1553.9%) |
| June 2020 | - | $3.19 M(-337.1%) | $4.00 M(+146.9%) |
| Mar 2020 | - | -$1.34 M(-1002.7%) | $1.62 M(-3.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | $1.68 M(-157.8%) | $149.00 K(-92.6%) | $1.68 M(+61.6%) |
| Sept 2019 | - | $2.01 M(+149.6%) | $1.04 M(-181.7%) |
| June 2019 | - | $806.00 K(-162.6%) | -$1.27 M(-49.5%) |
| Mar 2019 | - | -$1.29 M(+162.3%) | -$2.52 M(-13.4%) |
| Dec 2018 | -$2.91 M(+65.7%) | -$491.00 K(+64.2%) | -$2.91 M(-27.6%) |
| Sept 2018 | - | -$299.00 K(-31.9%) | -$4.01 M(-15.6%) |
| June 2018 | - | -$439.00 K(-73.8%) | -$4.76 M(+17.1%) |
| Mar 2018 | - | -$1.68 M(+5.1%) | -$4.06 M(+131.6%) |
| Dec 2017 | -$1.75 M(-184.0%) | -$1.60 M(+53.1%) | -$1.75 M(-215.3%) |
| Sept 2017 | - | -$1.04 M(-509.0%) | $1.52 M(-30.0%) |
| June 2017 | - | $255.00 K(-59.6%) | $2.17 M(-30.7%) |
| Mar 2017 | - | $631.00 K(-62.4%) | $3.13 M(+50.1%) |
| Dec 2016 | $2.09 M(-147.1%) | $1.68 M(-528.1%) | $2.09 M(-131.0%) |
| Sept 2016 | - | -$392.00 K(-132.2%) | -$6.74 M(+34.9%) |
| June 2016 | - | $1.22 M(-392.8%) | -$5.00 M(-19.6%) |
| Mar 2016 | - | -$416.00 K(-94.2%) | -$6.22 M(+7.2%) |
| Dec 2015 | -$4.44 M(+458.8%) | -$7.15 M(-629.5%) | -$5.80 M(-529.5%) |
| Sept 2015 | - | $1.35 M | $1.35 M |
| Dec 2014 | -$794.00 K | - | - |
FAQ
- What is Fulgent Genetics annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Fulgent Genetics?
- What is Fulgent Genetics annual EBITDA year-on-year change?
- What is Fulgent Genetics quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Fulgent Genetics?
- What is Fulgent Genetics quarterly EBITDA year-on-year change?
- What is Fulgent Genetics TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Fulgent Genetics?
- What is Fulgent Genetics TTM EBITDA year-on-year change?
What is Fulgent Genetics annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of FLGT is -$67.45 M
What is the all time high annual EBITDA for Fulgent Genetics?
Fulgent Genetics all-time high annual earnings before interest, taxes, depreciation & amortization is $686.96 M
What is Fulgent Genetics annual EBITDA year-on-year change?
Over the past year, FLGT annual earnings before interest, taxes, depreciation & amortization has changed by -$281.61 M (-131.49%)
What is Fulgent Genetics quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of FLGT is -$12.60 M
What is the all time high quarterly EBITDA for Fulgent Genetics?
Fulgent Genetics all-time high quarterly earnings before interest, taxes, depreciation & amortization is $268.84 M
What is Fulgent Genetics quarterly EBITDA year-on-year change?
Over the past year, FLGT quarterly earnings before interest, taxes, depreciation & amortization has changed by -$25.95 M (-194.37%)
What is Fulgent Genetics TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of FLGT is -$80.98 M
What is the all time high TTM EBITDA for Fulgent Genetics?
Fulgent Genetics all-time high TTM earnings before interest, taxes, depreciation & amortization is $759.64 M
What is Fulgent Genetics TTM EBITDA year-on-year change?
Over the past year, FLGT TTM earnings before interest, taxes, depreciation & amortization has changed by -$36.13 M (-80.53%)